Reply: International estimates on infertility prevalence and treatment seeking: potential need and demand for medical care Sir, We welcome the in-depth attention Dyer gave our article on the international prevalence of infertility. Dyer questioned the validity of our conclusion on the basis of misinterpretation of original data, omission of relevant studies and extrapolation of data that was not representative across regions.
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In our study, we identified 25 population surveys evaluating infertility prevalence and reported the current median 12-month infertility prevalence to be 9% for more (3.5 -16.7%) and less developed (9.2 -9.3%) countries excluding studies using a 24 month period. Although this exclusion was made clear in the Results we did not re-iterate it in the Discussion or the Abstract and we agree with Dyer that this omission might have led to confusion about the pool of studies that were used to generate our median prevalence. It is of interest that where 12 and 24 month estimates were available from the same study, the difference was not large (8.5 and 7%, respectively) (Royal Commission, 1993) .
The prevalence of 9% for the less developed countries was also queried in respect to the inclusion of three studies conducted in the Gambia, Tanzania and China (Sundby et al., 1998; Che and Cleland, 2002; Larsen, 2005) . Dyer states that two of these studies did not measure 12-month infertility (Larsen and Sundby) . In the original Table I we did indicate that the Larsen study used a 24 month prevalence rate and that study was excluded from our calculation of the median prevalence (see p. 1508 of our article). As noted by Dyer, Sundby examined separately current primary infertility of at least 1 year (3.2%, p. 894 her article) and secondary infertility (6%, p. 894) for a 3 year period and we used her summative value (9.2%) in our current estimate when we should have used only the current primary infertility value.
Dyer also draws our attention to other relevant publications omitted from our review: the publication by Adetoro and Ebomoyi (1991) reporting prevalence in Nigeria and the work in Gabon by Schrijvers et al. (1991) . The Demographic and Health Surveys Comparative Report (Rutstein and Shah, 2004) was examined and we excluded it because much of the Larsen (2000) and Ericksen and Brunette (1996) paper on prevalence in Sub-Saharan Africa are based on the DHS data and we wanted to avoid duplication in our reporting. We concur however that as the Rutstein and Shah report is more comprehensive we should have used this one (excluding the China estimate due to single child policies). Since publication of our article we also obtained another study on current infertility in Iran (Ahmadi Asr Badr et al., 2006) and found additional data embedded in Fuentes and Devoto (1994) on current infertility in Chile.
Given the letter from Dyer and correspondence from other readers, we believe presentation of the overall and separate (primary and secondary) prevalence rates would be a useful update of our original article (see updated Table I ). Only 63.0% (n ¼ 17) provided separate estimates and four studies (van Balen et al., 1997; Zargar et al., 1997; Che and Cleland, 2002; Liu et al., 2005) only examined primary infertility. In most studies (78%) primary infertility was defined as no history of previous pregnancy and secondary infertility as a history of at least one previous pregnancy before the period of infertility. The remaining studies used a history/no history of live birth.
In updated Table I the current median 12-month infertility prevalence for more developed countries remains the same (n ¼ 5, 9% median, 3.5 -16.7% range) but is slightly lower in less developed countries about 6% (n ¼ 4, 3.2 -9.3% range). However, the main revelation from Table I is that presentation of an overall prevalence rate masks underlying differences between more and less developed countries in primary and secondary estimates that when combined give the impression of similarity. In reality the data suggest that women in more developed countries have higher rates of primary infertility compared with women in less developed countries (7.7 versus 4.5%, respectively) whereas the reverse is true with secondary infertility which is higher in women from less developed countries (8.5 versus 13.4%, respectively).
We agree with Dyer that it is difficult to make cross country comparisons because of significant conceptual and methodological heterogeneity. Indeed researchers use different definitions of infertility (subfertility, infecundity, primary, secondary, no live birth versus no conception, varying periods of post-marital childlessness) and different denominator populations (e.g. 'at risk of pregnancy'/exposed populations versus no use of contraception, versus married versus all . Reply: Influence of activating and inhibiting killer immunoglobulinlike receptors on predisposition to recurrent miscarriages Sir, We thank Moffett and Hiby for their interest in our paper entitled 'Influence of activating and inhibiting killer immunoglobulin-like receptors on predisposition to recurrent miscarriages'. We share their concern regarding the association of KIRs in recurrent miscarriages in the light of existing confusions and conflicting reports. We undertook this study while being fully aware of the various reports published prior to this one concerning this issue and that there has not been a clear consensus established to date regarding the role of KIRs in the feto-maternal interactions and as predisposing factors to recurrent miscarriage (RM).
In the introduction as well as in the discussion of our paper, we have provided the details of other studies reported prior to our study which includes the following. (2008) reported an association between the maternal KIR repertoire and HLA-Cw alleles in 67 and 73 RM couples, respectively. To the best of our understanding, the possible reasons for this disparity could be:
(i) Relatively smaller sample sizes of recurrent miscarriage patients and different selection criteria opted by different workers. This warrants a methodical and well planned meta-analysis to be carried out on this subject. (ii) The influence of different ethnic groups, while conducting such studies on the outcome of KIR frequencies, as KIR genotypes have a wide geographical distribution. (iii) The methodology used for genotyping the KIRs is almost invariably the PCR-SSP technique in all the previous studies.
We planned our study keeping in mind the conflicting data available on the role of KIR in feto-maternal interactions. The main objective was to evaluate these markers in the ethnically diverse population from the Indian subcontinent. We have considered all the abovementioned points to decrease the discrepancy in our data i.e. sample size, exclusion-inclusion criterion for patient selection; selection of ethnically matched RM controls fulfilling the criteria of at least three live births and no history of miscarriages, pre-eclampsia, pre-term delivery and ectopic pregnancy; and selection of the reliable and most recent PCR-SSP protocol at the time of the commencement of this study. We had followed the following strategy during the course of sample selection for this study: we initially collected samples from 526 RM patients and screened them for various known causes of miscarriages (as mentioned in the Methods section of the manuscript). After excluding those who do not fit into our inclusion criteria (including the secondary aborters), we were left with 205 cases (39%) of varied ethnic distribution within the North Indian region. We then selected the control women from the renal transplant donors at our center. The healthy parous females who had at least three live
